SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc.
VASO 0.150-2.0%Nov 26 3:08 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TimF who wrote (1553)5/31/2003 4:49:20 PM
From: Richard James  Read Replies (1) of 1605
 
I doubt that it is a message board post relating that Ali did one EECP treatment is to take a full course this summer. That could be huge later if he takes the treatments and if his Parkinson's regresses.

It looks as if someone wanted a quarter million shares on the 28th. Why? Rumor is that it was Fidelity. Could be sales leaked, doubtful that it had to do with Russell reconstitution. All we know is that the 37% medicare rate increase took effect at he beginning of the quarter ending today and that the rate increase should have turned EECP from a marginal profit or loss to a soled profit center.

The release re Cash's appointment as CEO shouldn't be the reason, but he may have been made CEO as a result of improvements in the fourth quarter.

It just looks as if VASO may be turning the corner and gathering some momentum. Increased acceptance in the medical community; vastly better reimbursement; many have hoped for a celebrity patient (Ali); CHF was approved by the FDA, PEECH should be about 70% enrolled with much of the data pouring in.

Perhaps more than anything,Vasomedical is a real company with a real product that meets a real need that it has been selling for a profit, noting that it quickly bounced back from the Heartgen fiasco. (Heartgen is still in business at two locations.)

Then it doesn't take much to make a double or triple off a $1 stock.

The next few days will be damned interesting. Nothing like following up the appointment of a new CEO with a release demonstrating a turnaround since his recent hiring as COO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext